Clinical Trials Directory

Trials / Completed

CompletedNCT04512924

The Psychosocial Outcomes in Caregivers of Children With Food Allergy

Food Allergy Symptom Self-management With Technology (FASST) for Caregivers: An mHealth Intervention to Address Psychosocial Outcomes in Caregivers of Children With Newly Diagnosed Food Allergy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate use of a mobile application (also commonly referred to as an app) designed to support caregivers of children with newly diagnosed food allergy. This study has 2 phases. In Phase 1, the researchers obtained feedback regarding use of mobile apps from caregivers who have been managing their child's food allergy for one year or more. The researchers then used this feedback to build a mobile app for caregivers of children with newly diagnosed food allergy. In Phase 2, the researchers will evaluate the mobile app during a 4-week evaluation period with a group of caregivers of children newly diagnosed with food allergy. The data obtained from this study will hopefully benefit caregivers of children with newly diagnosed food allergy.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEnhanced mobile app with standard of care and educationGroup 1 will download an enhanced mobile app that will include education and support resources related to food allergy and its management.
BEHAVIORALEnhanced mobile app with standard of care, education and support resourcesGroup 2 will download an enhanced mobile app that will include education and support resources related to food allergy and its management, a symptom monitoring and tracking system that allows mobile app users to log symptoms they may experience as caregivers of children newly diagnosed with food allergy, e.g. fatigue and anxiety, and symptom based interventions (recommendations) that may improve a caregiver's ability to self-manage experienced symptoms.

Timeline

Start date
2020-12-08
Primary completion
2022-04-30
Completion
2022-04-30
First posted
2020-08-14
Last updated
2025-08-11
Results posted
2025-08-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04512924. Inclusion in this directory is not an endorsement.